NexgenRx Inc.
NEGXF
$0.19
$0.002.55%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 443.65% | 4,242.44% | 1,124.09% | 285.90% | 182.73% |
| Total Depreciation and Amortization | 24.16% | 15.21% | 7.61% | 12.09% | -82.53% |
| Total Amortization of Deferred Charges | -9.14% | -9.14% | -9.14% | -9.14% | -- |
| Total Other Non-Cash Items | 500.84% | 244.87% | 465.43% | 447.74% | -69.56% |
| Change in Net Operating Assets | 4.54% | -464.33% | -454.07% | -709.79% | 28.96% |
| Cash from Operations | 144.96% | 7.39% | 41.05% | -34.93% | 144.70% |
| Capital Expenditure | -362.77% | -179.67% | -9.20% | -8.90% | -125.88% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -84.98% | -198.64% | -138.75% | -188.00% | -36.19% |
| Cash from Investing | -143.81% | -190.93% | -100.58% | -132.47% | -515.88% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -29.61% | -40.38% | -39.95% | -29.17% | -25.13% |
| Issuance of Common Stock | -100.00% | -66.67% | -66.67% | 200.00% | 200.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -2.99% | 37.37% | 39.60% | 39.36% | -66.50% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -26.67% | 25.66% | 29.31% | 53.33% | -44.85% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 782.45% | -41.98% | 418.23% | -250.06% | -97.58% |